BEGHE', Bianca
 Distribuzione geografica
Continente #
NA - Nord America 18.842
AS - Asia 8.010
EU - Europa 7.512
SA - Sud America 1.146
Continente sconosciuto - Info sul continente non disponibili 262
AF - Africa 182
OC - Oceania 55
Totale 36.009
Nazione #
US - Stati Uniti d'America 18.592
SG - Singapore 2.465
GB - Regno Unito 2.345
IT - Italia 2.037
CN - Cina 1.987
HK - Hong Kong 1.044
BR - Brasile 866
VN - Vietnam 796
SE - Svezia 526
DE - Germania 510
FI - Finlandia 459
BD - Bangladesh 402
UA - Ucraina 350
FR - Francia 308
RU - Federazione Russa 307
KR - Corea 247
TR - Turchia 215
ID - Indonesia 209
IN - India 156
BG - Bulgaria 151
CA - Canada 114
AR - Argentina 95
NL - Olanda 87
MX - Messico 79
IQ - Iraq 69
ZA - Sudafrica 66
PK - Pakistan 61
CO - Colombia 60
ES - Italia 55
AU - Australia 50
JP - Giappone 45
IE - Irlanda 44
RO - Romania 44
AT - Austria 41
AE - Emirati Arabi Uniti 37
MY - Malesia 36
PL - Polonia 36
CL - Cile 30
VE - Venezuela 30
BE - Belgio 29
LT - Lituania 29
IR - Iran 28
CH - Svizzera 26
EC - Ecuador 26
SA - Arabia Saudita 22
PH - Filippine 20
TH - Thailandia 19
NP - Nepal 17
JO - Giordania 16
PY - Paraguay 16
KE - Kenya 15
RS - Serbia 15
PT - Portogallo 14
TW - Taiwan 14
UZ - Uzbekistan 14
CZ - Repubblica Ceca 13
EG - Egitto 13
MA - Marocco 13
SY - Repubblica araba siriana 13
TN - Tunisia 13
DO - Repubblica Dominicana 11
AL - Albania 10
DZ - Algeria 10
IL - Israele 10
JM - Giamaica 10
KZ - Kazakistan 10
CR - Costa Rica 9
UY - Uruguay 9
AZ - Azerbaigian 8
BF - Burkina Faso 8
ET - Etiopia 8
MD - Moldavia 8
NO - Norvegia 8
PE - Perù 8
SI - Slovenia 8
HU - Ungheria 7
OM - Oman 7
BO - Bolivia 6
EE - Estonia 6
LB - Libano 6
NG - Nigeria 6
NI - Nicaragua 6
BA - Bosnia-Erzegovina 5
BH - Bahrain 5
DK - Danimarca 5
GR - Grecia 5
KG - Kirghizistan 5
LV - Lettonia 5
MK - Macedonia 5
NZ - Nuova Zelanda 5
PR - Porto Rico 5
PS - Palestinian Territory 5
AO - Angola 4
BY - Bielorussia 4
LY - Libia 4
MN - Mongolia 4
PA - Panama 4
QA - Qatar 4
SN - Senegal 4
CG - Congo 3
Totale 35.696
Città #
Ashburn 1.722
Fairfield 1.600
Southend 1.563
Santa Clara 1.461
Singapore 1.459
Hong Kong 1.025
Woodbridge 979
Chandler 922
Houston 825
San Jose 683
Hefei 672
Jacksonville 654
Chicago 627
Seattle 571
Wilmington 563
Cambridge 513
Dearborn 497
Los Angeles 424
London 414
Ann Arbor 360
Beijing 349
Council Bluffs 343
Helsinki 335
Salt Lake City 283
New York 280
Modena 246
Nyköping 238
Ho Chi Minh City 232
Hanoi 224
Seoul 221
Milan 210
The Dalles 210
San Diego 190
Dallas 174
Princeton 160
Tampa 149
Sofia 145
Rome 141
Elk Grove Village 133
Eugene 115
Lauterbourg 113
Buffalo 110
São Paulo 96
Jakarta 94
Izmir 93
Moscow 82
Redwood City 75
Naples 74
Des Moines 73
Lancaster 67
Frankfurt am Main 66
Shanghai 66
Sterling 60
Columbus 56
Boardman 54
Phoenix 47
Da Nang 43
Miami 43
Orem 42
Bologna 39
Atlanta 37
Dublin 37
Nuremberg 37
Falls Church 35
Detroit 34
Tokyo 34
Kansas City 31
Toronto 31
Bogotá 29
Grafing 29
Verona 29
Munich 28
Mexico City 27
Redondo Beach 27
Ankara 26
Florence 26
Haiphong 26
Kent 26
Rio de Janeiro 26
Dulles 25
Norwalk 25
Baghdad 24
Belo Horizonte 24
Chennai 24
Warsaw 24
Johannesburg 23
Miano 23
Palermo 23
San Francisco 23
Bari 22
Brooklyn 22
Montreal 21
Nanjing 21
Vienna 21
Brussels 19
Buenos Aires 19
Charlotte 19
Genoa 19
Amsterdam 18
Jersey City 18
Totale 24.337
Nome #
The genetic basis of atopic asthma. 844
Asma bronchiale 666
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 491
The Burden of Image Based Emphysema and Bronchiolitis in HIV-Infected Individuals on Antiretroviral Therapy 487
Three-year hospitalization and mortality in elderly smokers with COPD or CHF. 393
Chronic respiratory abnormalities in the multi-morbid frail elderly 390
Acute severe asthma: management and treatment. 384
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. 381
Effectiveness of pulmonary rehabilitation in patients with INTERSTITIAL LUNG DISEASE of different etiology: a multicenter prospective study 378
Airway inflammation in childhood asthma 372
Physiologic consequences of long term inflammation 352
Lack of association of HLA class I genes and TNF alpha-308 polymorphism in toluene diisocyanate-induced asthma. 352
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections 347
Comparison of two methods of processing induced sputum: selected versus entire sputum. 344
Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis 344
Treatment of chronic obstructive pulmonary disease and its comorbidities 334
Update in Chronic Obstructive Pulmonary Disease 2005 332
Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure 332
La broncopneumopatia cronica ostruttiva nell'anziano 332
Roflumilast:un nuovo farmaco per il trattamento della BPCO 331
Comparison of three methods for single nucleotide polymorphism typing for DNA bank studies: sequence-specific oligonucleotide probe hybridisation, TaqMan liquid phase hybridisation, and microplate array diagonal gel electrophoresis (MADGE). 325
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 325
Exacerbation of respiratory Symptoms in COPD patients may not be exacerbations of COPD 323
Complex chronic co-morbidities of COPD 320
Use of adjunctive cardiovascular therapy in patients hospitalized for acute exacerbations of COPD. 320
Inhaled Corticosteroids in COPD: Pros and Cons. 319
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 319
Update in chronic obstructive pulmonary disease 2006 318
Microsatellite alterations suggestive of organ-specific asthma and atopy in exhaled breath condensate 318
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 315
Acute exacerbations of chronic obstructive pulmonary disease provide a unique opportunity to take care of patients 313
Linkage analysis of the 5q31-33 candidate region for asthma in 240 UK families. 312
Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease 308
Transforming growth factor-β type II receptor in pulmonary arteries of patients with very severe COPD 304
Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma. 303
La genetica dell’asma bronchiale. 301
Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population. 300
Acute exacerbations of chronic obstructive pulmonary disease: are antibiotics needed? 297
The cysteinyl-leukotriene type 1 receptor polymorphism 927T/C is associated with atopy severity but not with asthma 296
Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease 296
Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players. 295
Cardiovascular mechanisms of death in severe COPD exacerbation: time to think and act beyond guidelines 290
[Pathology of chronic obstructive pulmonary disease] 288
Baseline exercise tolerance and perceived dyspnea to identify the ideal candidate to pulmonary rehabilitation: a risk chart in COPD patients. 284
Role for CXCR6 and its Ligand CXCL16 in the Pathogenesis of T-cell Alveolitis in Sarcoidosis 281
Leukotriene B4 receptor locus gene characterisation and association studies in asthma 276
COPD and the Solar System:Introducing the Chronic Obstructive Pulmonary Disease Comorbidome 273
Quality of life and intrinsic capacity in patients with post-acute COVID-19 syndrome is in relation to frailty and resilience phenotypes. 272
Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice 272
We Have to Learn to Do Without Knowing Enough: Anti-Eosinophilic Treatments for Severe Asthma 272
Alveolar and bronchiolar inflammation in COPD 270
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 265
Eosinophilia in asthma: the easy way is not always the best 263
Significant chronic airway abnormalities in never-smoking HIV-infected patients 262
Nasal pressure swings as the measure of inspiratory effort in spontaneously breathing patients with de novo acute respiratory failure 259
Basi strutturali della BPCO. 255
Pulmonary comorbidities associated with chronic obstructive pulmonary disease 255
Phosphodiesterase-4 Inhibitor Therapy for Lung Diseases 254
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs 252
La NIV nel paziente con insufficienza respiratoria cronica, la gestione domiciliare - Competenza specialistica nelle patologie pneumologiche pure 251
Polymorphisms in the interleukin-4 and interleukin-4 receptor α chain genes confer susceptibility to asthma and atopy in a Caucasian population 250
Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome. 245
The multiple components of COPD 241
Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice 239
Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis 237
Triple therapy for symptomatic patients with COPD 235
Tissue polypeptide specific antigen (tps) and cytokeratin 19 fragment (CYFRA 21.1) immunoradiometric assay in non small cell lung cancer evaluation. 232
Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease. 231
Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease. 231
Copd, pulmonary fibrosis and ilas in aging smokers: The paradox of striking different responses to the major risk factors 231
Genetic influences on Asthma Severity. 230
Chronic Obstructive Pulmonary Disease is just one component of the complex multimorbidities in patients with COPD. 230
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis 227
What is the origin of dyspnoea in smokers without airway disease ? 222
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. 221
Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials 217
Evaluation of the serum markers CEA, NSE, TPS and CYFRA 21.1 in lung cancer. 213
Pathology of COPD and asthma 211
Identifying and Treating COPD in Cardiac Patients 211
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact 210
Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. 208
Reply: look at the moon, not just at the finger indicating the moon 206
Peripheral eosinophil count as a biomarker for the management of COPD: not there yet. 205
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. 202
Trattamento farmacologico dell’asma bronchiale 201
Neutrophilic infiltration within the airway smooth muscle in patients with COPD 201
Asthma 201
Update in Asthma 2016 197
Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema 197
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) 196
Cardiac Diseases and respiratory consequences 195
Blood eosinophils for the management of COPD patients? 195
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation 194
COPD in the elderly is almost invariably associated with one or more chronic comorbidities 187
Airway inflammation in severe chronic obstructive pulmonary disease - Relationship with lung function and radiologic emphysema 185
Trattamento farmacologico dell’asma bronchiale. 179
La broncopneumopatia cronica ostruttiva 178
Symptomatic elderly patients. The urgent need for comprehensive assessment and management 178
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology 177
Pharmacological prevention of COPD exacerbations 176
Totale 28.229
Categoria #
all - tutte 157.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 157.416


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.809 0 297 234 234 94 132 169 157 339 261 559 333
2022/20232.473 254 253 132 220 288 355 83 276 343 64 107 98
2023/20241.997 83 140 114 264 355 207 130 213 87 92 116 196
2024/20256.209 225 174 100 406 1.104 935 289 266 710 343 678 979
2025/202611.979 630 463 876 1.605 2.459 829 1.370 485 933 905 782 642
2026/2027375 375 0 0 0 0 0 0 0 0 0 0 0
Totale 36.009